Vitalea Science

Vitalea Science is a specialized contract research organization (CRO) that provides advanced bioanalytical services using Accelerator Mass Spectrometry (AMS) technology. Founded in 2003 and now a part of Pharmaron, the company focuses on ultra-sensitive detection for clinical studies, including microdosing, absolute bioavailability, and mass balance assessments. Their proprietary Bio-AMS platform allows for the quantification of Carbon-14 labeled drugs at attomole levels, significantly reducing the radioactive dose required for human subjects. The company serves the pharmaceutical and biotech industries by streamlining drug development and providing precise pharmacokinetic data.